Arkolith/Insider Trading/QNRX/Form 4

Carter Denise P.

Chief Operating Officer, DirectorQuoin Pharmaceuticals, Ltd. (QNRX) · full profile →Form 4 · filed Dec 27, 2024
Net Buying
Open-Market Buys
$250K
Open-Market Sells
$0
Net Open-Market Flow
$250K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2024Buy(P)556K$0.45$250K603K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2024Buy(P)556K——556K
Dec 23, 2024Buy(P)556K——556K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-132190) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML